Home
>
US Stocks
>
Agios Pharmaceuticals Inc
Agios Pharmaceuticals Inc
AGIO

Agios Pharmaceuticals Inc (AGIO)

$48.6510.69%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
47.32
Today Low/High
47.21 / 48.68
52 Week Low/High
$32.47 / $62.16
P/E ratio
1.65
Market Cap
$2.63B

Company Details

Agios is focused on discovering and developing novel investigational medicines to treat malignant hematology, solid tumors and rare genetic diseases through scientific leadership in the field of cellular metabolism. In addition to an active research and discovery pipeline across these three therapeutic areas, Agios has two approved oncology precision medicines and multiple first-in-class investigational therapies in clinical and/or preclinical development.
Organisation
Agios Pharmaceuticals Inc
Headquaters
Cambridge, Massachusetts, US
Employees
562
Industry
Health Technology
CEO
Jacqualyn Fouse

Discover more

Frequently Asked Questions

What is Agios Pharmaceuticals Inc (AGIO) share price today?

Can Indians buy Agios Pharmaceuticals Inc (AGIO) shares?

How can I buy Agios Pharmaceuticals Inc (AGIO) shares from India?

Can Fractional shares of Agios Pharmaceuticals Inc (AGIO) be purchased?

What are the documents required to start investing in Agios Pharmaceuticals Inc (AGIO) stocks?

We are a SEBI registered investement advisor